Back to Neuberger Berman Group LLC Neuberger Berman Group LLC

MNPRMNPR
3 quarters

Position history for Neuberger Berman Group LLCNeuberger Berman Group LLC's holdings in MONOPAR THERAPEUTICS INC

Yes. Neuberger Berman holds 55,194 shares of MNPR (Monopar Therapeutics), worth $5.1M, as of its Q2 2026 13F filing. It increased the position by 12,760 shares (+30.1%) from Q1 2026. Neuberger Berman has held MNPR since Q4 2025, across 3 quarterly 13F filings.

Current Value

$5.1M

Current Shares

55,194

Total Value Change

+$3M

Total Shares Change

+22,647

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
55,194
+30.1%
$5.1M0.0%$92.59
34
2026-Q1
Increased
42,434
+30.4%
$2.3M0.0%$54.79
33
2025-Q4
New
32,547
-
$2.1M0.0%$65.30
36

Other major holders of MNPR: Jupiter Topco LLC, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used